pharma · Human Immunodeficiency Virus
Beijing Cotimes Biotech
Beijing 302 Hospital
Beijing 302 Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Human Immunodeficiency Virus. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(
Beijing, CN HQ
3 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 3
- Programs
- 1
- Drugs
- 1
- Patents
- 0
TwHF
Phase 2 · small molecule · Human Immunodeficiency Virus
TwHF for Human Immunodeficiency Virus is a Phase 2 program (small_molecule) at Beijing 302 Hospital with 1 ClinicalTrials.gov record(s).
Internal code Beijing302-007
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Beijing 302 Hospital
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Human Immunodeficiency Virus
- Status
- active
- Trials
- 1